Search results

Global COVID vaccine roll-out will face many hurdles

Location:

INT

Initial data are expected to become available before the end of the year, and subject to evidence of safety and efficacy, to be submitted for approval and fast-tracked so that a…

Vaccine woes will deepen polarisation in Argentina

Location:

ARGENTINA

A rise in cases and deaths has increased pressure on the government over its sluggish vaccine roll-out. Despite an announcement recently that a local laboratory will soon begin…

Vaccine nationalism could prolong pandemic

Location:

INT

Klugge is likely aiming to be optimistic. An effective COVID-19 vaccine is considered to be the only economically and humanely acceptable exit strategy for this pandemic…

China and Russia tactics will undercut their vaccines

Location:

CHINA/RUSSIA

For Russia, it would be a chance for international acclaim and to stoke national pride. For China, success would offset its shortcomings in responding to the emergence of COVID-19…

Controversies could fuel COVID-19 vaccine hesitancy

Location:

INT

Scientists and governments are increasingly concerned that ‘vaccine hesitancy’, the situation of people delaying or refusing some or all vaccines, could reduce immunisation…

Organised crime will gain from world vaccine shortages

Location:

INT

However, it is vast global demand for the restricted supply of COVID-19 vaccines that offers the most alluring prize for criminal gangs. Black markets thrive in situations where…

India will not revive vaccine shipments until 2022

Location:

INDIA

India suspended its ‘vaccine diplomacy’ in April, choosing to prioritise shots for its own population, as it came under pressure from a massive second wave of COVID-19 infections…

Central America’s vaccine efforts face mixed prospects

Location:

CENTRAL AMERICA

Elsewhere in the region, only Panama has so far received a first vaccine shipment, suggesting roll-outs initially will be patchy. Central American governments are sourcing their…

First COVID-19 vaccine may not end all distancing

Location:

INTERNATIONAL

While studies show that patients mount an immunity to the virus (at least in the short term) and immediate re-infection is highly unlikely, it is estimated that some 90% of the…

India’s key vaccine challenge is at home, not abroad

Location:

INDIA

Its vaccine production capacity has increased in the intervening period to the extent that it now has a surplus of doses, even allowing for supplies abroad. A key reason why so…